Matthew Adams
Family · Dalton, GANPI 1255754461
Payments from drug & device makers
Across 560 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- Jazz Pharmaceuticals Inc.$1K
- AstraZeneca$916
- Boehringer Ingelheim$902
- Insmed, Inc.$857
- Grifols USA, LLC$720
- plus $5K from 25 others
What the payments were for
- Food & beverage$11,07599%
- Education$1491%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 108 | $1,824 |
| Jazz Pharmaceuticals Inc. | 48 | $1,112 |
| AstraZeneca | 33 | $916 |
| Boehringer Ingelheim | 63 | $902 |
| Insmed, Inc. | 34 | $857 |
| Grifols USA, LLC | 36 | $720 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $639 |
| United Therapeutics Corporation | 19 | $435 |
| Sanofi | 20 | $405 |
| Axsome Therapeutics, Inc. | 23 | $397 |
| Actelion Pharmaceuticals US, Inc. | 19 | $387 |
| Mylan Specialty L.p. | 16 | $358 |
| Mallinckrodt Hospital Products Inc. | 11 | $328 |
| Baxter Healthcare | 16 | $294 |
| Avadel CNS Pharmaceuticals, LLC | 14 | $291 |
| Regeneron Healthcare Solutions, Inc. | 12 | $260 |
| Harmony Biosciences LLC | 9 | $195 |
| Vifor Pharma, Inc. | 6 | $142 |
| Inspire Medical Systems, Inc. | 4 | $138 |
| Verona Pharma, Inc. | 8 | $135 |
| ANI Pharmaceuticals, Inc. | 6 | $119 |
| Viatris Specialty LLC | 5 | $85 |
| Sunovion Pharmaceuticals Inc. | 5 | $67 |
| Pulmonx Corporation | 3 | $63 |
| Johnson & Johnson | 1 | $36 |
| Advanced Respiratory, Inc | 2 | $28 |
| Vapotherm Inc | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Amgen | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,224 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 488 | $371,864 |
| OpsumitMacitentan | 23 | $290,234 |
| OfevNintedanib Esylate | 16 | $207,034 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 126 | $92,763 |
| Breo ElliptaFluticasone/Vilanterol | 172 | $81,403 |
| NucalaMepolizumab | 19 | $70,088 |
| Spiriva RespimatTiotropium Bromide | 67 | $53,085 |
| SymbicortBudesonide/Formoterol Fumarate | 135 | $39,100 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 71 | $34,041 |
| Advair HfaFluticasone Propion/Salmeterol | 61 | $32,793 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 674 | $19,386 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $14,725 |
| Incruse ElliptaUmeclidinium Bromide | 32 | $13,722 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $9,791 |
| Spiriva HandihalerTiotropium Bromide | 15 | $9,673 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Nucala, Anoro Ellipta, Incruse Ellipta | $1,824 | $577,585803 claims |
| Actelion Pharmaceuticals US, Inc.Opsumit | $387 | $290,23423 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat | $902 | $284,635110 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $916 | $138,085275 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.
Other family in Dalton
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.